Onding to cells transfected with meganuclease in absence of TDT. (DOC) Table S2 Targeted mutagenesis data. Nucleases encoding plasmids were transfected with or purchase 76932-56-4 without DNA-end processing enzyme encoding plasmids in 10 mg of total DNA. Cells were harvested 3 days post-transfection for genomic DNA extraction and locus specific PCR amplification for deep sequencing analysis. Several thousands of sequences were obtained per PCR product and then analyzed for site-specific insertion or deletion events. (DOC)proteins used in this study. scTrex2: Single chain molecule of Trex2 exonuclease. Two Trex2 monomers were fused together using the linker 1 : TPPQTGLDVPY. ScTrex-meganuclease: meganuclease results from the fusion of two engineered monomers linked by linker 2.. The single chain meganuclease was then fused by its N-t domain to the single chain Trex2 using the linker 3. The resulting molecule harbors endonuclease and 39-.59exonuclease activity. (DOCX)Figure S1 Deletion pattern induced by MN in the presence of Tdt. Deletion events induced by RAG1m (A) DMD21m (B) or CAPNS1m (C) in the presence (green) or absence (blue) of Tdt were analyzed. Deletion sizes are represented as percentage of total deletion events. Note that CAPNS1m induces large and diverse deletions that were analyzed by deletion classes (range of deletions size). (EPS) Figure S2 Targeted mutagenesis pattern induced by MNs in the presence of Trex or scTrex. Percentages of TM events induced by RAG1m (A) DMD21m (B) or CAPNS1m (C) with or without (empty) Trex or scTrex are shown. Del2, 2 bp deletion; Del3, 3 bp deletion; Del4, 4 bp deletion; Other, more than 4 bp Deletions as well as other TM events induced byAcknowledgmentsWe thank the Cardiovascular Research Center (Mount Sinai School of Medicine, York, USA) for iPS cells.Author ContributionsConceived and designed the experiments: F. Delacote CP RM GS PD F. ^ Daboussi. Performed the experiments: F. Delacote CP VG MD CR NO ^ RM F. Daboussi. Analyzed the data: GS F. Daboussi PD FP. Contributed Anlotinib chemical information reagents/materials/analysis tools: RM MD. Wrote the paper: F. Delacote ^ CP PD FP.Methods to Improve Targeted Mutagenesis
Diabetic and non-diabetic glomerular diseases remain the major cause of chronic and end-stage renal disease [1]. Proteinuria is an indicator of kidney disease and is largely caused by glomerular disease, such as diabetes or glomerulonephritis [2]. Numerous studies have focused on the roles of podocytes, the glomerular basement membrane (GBM) and mesangial cells in the pathogenesis of proteinuria and glomerulosclerosis [3?]. The importance of glomerular endothelial cells in glomerular injury has 
been largely ignored. Recent studies have demonstrated that endothelial nitric oxide synthatase (eNOS) deficiency exacerbates renal injury in anti-GBM [6] 1527786 and remnant kidney models [7] and accelerates diabetic kidney damage with features that resemble human diabetic nephropathy (DN) [8?1]. In patients, eNOS polymorphisms that lead to decreased eNOS expression and activity have been associated with advanced DN and progressive IgA nephropathy [12?4]. Scavengers of endothelial nitric oxide (NO)production, such as asymmetric dimethyl-arginine or N-Nitro-LArginine Methyl Ester (L-NAME) can acutely increase glomerular permeability and induce proteinuria [15?7]. Collectively, these studies suggest that endothelial dysfunction is involved in thedevelopment of diabetic and non-diabetic glomerular injury and renal fibrosis [18,19]. One of the mo.Onding to cells transfected with meganuclease in absence of TDT. (DOC) Table S2 Targeted mutagenesis data. Nucleases encoding plasmids were transfected with or without DNA-end processing enzyme encoding plasmids in 10 mg of total DNA. Cells were harvested 3 days post-transfection for genomic DNA extraction and locus specific PCR amplification for deep sequencing analysis. Several thousands of sequences were obtained per PCR product and then analyzed for site-specific insertion or deletion events. (DOC)proteins used in this study. scTrex2: Single chain molecule of Trex2 exonuclease. Two Trex2 monomers were fused together using the linker 1 : TPPQTGLDVPY. ScTrex-meganuclease: meganuclease results from the fusion of two engineered monomers linked by linker 2.. The single chain meganuclease was then fused by its N-t domain to the single chain Trex2 using the linker 3. The resulting molecule harbors endonuclease and 39-.59exonuclease activity. (DOCX)Figure S1 Deletion pattern induced by MN in the presence of Tdt. Deletion events induced by RAG1m (A) DMD21m (B) or CAPNS1m (C) in the presence (green) or absence (blue) of Tdt were analyzed. Deletion sizes are represented as percentage of total deletion events. Note that CAPNS1m induces large and diverse deletions that were analyzed by deletion classes (range of deletions size). (EPS) Figure S2 Targeted mutagenesis pattern induced by MNs in the presence of Trex or scTrex. Percentages of TM events induced by RAG1m (A) DMD21m (B) or CAPNS1m (C) with or without (empty) Trex or scTrex are shown. Del2, 2 bp deletion; Del3, 3 bp deletion; Del4, 4 bp deletion; Other, more than 4 bp Deletions as well as other TM events induced byAcknowledgmentsWe thank the Cardiovascular Research Center (Mount Sinai School of Medicine, York, USA) for iPS cells.Author ContributionsConceived and designed the experiments: F. Delacote CP RM GS PD F. ^ Daboussi. Performed the experiments: F. Delacote CP VG MD CR NO ^ RM F. Daboussi. Analyzed the data: GS F. Daboussi PD FP. Contributed reagents/materials/analysis tools: RM MD. Wrote the paper: F. Delacote ^ CP PD FP.Methods to Improve Targeted Mutagenesis
Diabetic and non-diabetic glomerular diseases remain the major cause of chronic and end-stage renal disease [1]. Proteinuria is an indicator of kidney disease and is largely caused by glomerular disease, such as diabetes or glomerulonephritis [2]. Numerous studies have focused on the roles of podocytes, the glomerular basement membrane (GBM) and mesangial cells in the pathogenesis of proteinuria and glomerulosclerosis [3?]. The importance of glomerular endothelial cells in glomerular injury has been largely ignored. Recent studies have demonstrated that endothelial nitric oxide synthatase (eNOS) deficiency exacerbates renal injury in anti-GBM [6] 1527786 and remnant kidney models [7] and accelerates diabetic kidney damage with features that resemble human diabetic nephropathy (DN) [8?1]. In patients, eNOS polymorphisms that lead to decreased eNOS expression 
and activity have been associated with advanced DN and progressive IgA nephropathy [12?4]. Scavengers of endothelial nitric oxide (NO)production, such as asymmetric dimethyl-arginine or N-Nitro-LArginine Methyl Ester (L-NAME) can acutely increase glomerular permeability and induce proteinuria [15?7]. Collectively, these studies suggest that endothelial dysfunction is involved in thedevelopment of diabetic and non-diabetic glomerular injury and renal fibrosis [18,19]. One of the mo.